Patient Education: Preventing Progression of Type 2 Diabetes: The Reflex to Use Pharmacological Therapy

2007 ◽  
Vol 1 (5) ◽  
pp. 358-359
Author(s):  
Martin Miner
Keyword(s):  
Type 2 Diabetes ◽  
Patient Education ◽  
Pharmacological Therapy

scholarly journals Pharmacological therapy and cardiovascular risk reduction for type 2 diabetes

2020 ◽  
Vol 66 (9) ◽  
pp. 1283-1288
Author(s):  
Eduardo Bello Martins ◽  
Eduardo Gomes Lima ◽  
Fábio Grunspun Pitta ◽  
Leticia Neves Solon Carvalho ◽  
Thiago Dias de Queiroz ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Cardiovascular Risk ◽  
Pharmacological Therapy ◽  
High Cardiovascular Risk ◽  
Cardiovascular Risk Reduction ◽  
Drug Classes ◽  
Clinical Benefits

SUMMARY The pharmacological therapy for type 2 diabetes mellitus has presented important advances in recent years, which has impacted the treatment of patients with established cardiovascular disease or with high cardiovascular risk. In this scenario, two drug classes have emerged and demonstrated clear clinical benefits: SGLT-2 inhibitors and GLP-1 agonists. The present review discusses the pharmacology, adverse effects, and clinical trials that have demonstrated the benefits of these medications in reducing cardiovascular risk.

Patient education in type 2 diabetes—A randomized controlled 1-year follow-up study

2007 ◽  
Vol 76 (3) ◽  
pp. 341-350 ◽  
Author(s):  
Eva Thors Adolfsson ◽  
Marie-Louise Walker-Engström ◽  
Bibbi Smide ◽  
Karin Wikblad
Keyword(s):  
Type 2 Diabetes ◽  
Patient Education ◽  
Follow Up Study ◽  
Randomized Controlled

scholarly journals Monitoring adherence to pharmacological therapy and follow-up examinations among patients with type 2 diabetes in community pharmacies. Results from an experience in Italy

PLoS ONE ◽  
2021 ◽  
Vol 16 (9) ◽  
pp. e0256478
Author(s):  
Teresa Spadea ◽  
Roberta Onorati ◽  
Francesca Baratta ◽  
Irene Pignata ◽  
Marco Parente ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Pharmacological Therapy ◽  
Public Health Issue ◽  
Individual Factors ◽  
Community Pharmacies ◽  
Antidiabetic Drug ◽  
Geographical Differences ◽  
Important Public Health

Introduction Type 2 diabetes is an important public health issue, yet adherence to drugs and regular clinical follow-up is still suboptimal. This study aims to evaluate a community pharmacy programme for monitoring and enhancing adherence to prescribed pharmacological therapies and recommended examinations among patients with confirmed diabetes. Methods The intervention was conducted in different Italian areas between April 2017 and January 2018. All adult patients who entered a pharmacy with a personal prescription for any antidiabetic drug and agreed to participate, were interviewed. Those found to be non-adherent received counselling from the pharmacists. All patients were invited for a follow-up interview after 3 months. Results Overall, 930 patients were enrolled and completed the baseline interview. We found low rates of non-adherence, ranging from 8% to 13% for prescribed pharmacological therapies, and 11–29% for the recommended clinical examinations. Non-adherence to oral therapies was higher among younger and recently diagnosed patients; that to clinical examinations was higher in men, those with an intermediate duration of diabetes and less educated patients. Large geographical differences persisted after the adjustment for individual factors. Only 306 patients (32.9%) returned for the follow-up interview, most of whom were already adherent at baseline. Conclusions Poor adherence to drugs or clinical examinations is not easy to identify in the usual operating setting of community pharmacies. Furthermore, the majority of patients did not return for follow-up, making it impossible to evaluate the efficacy of the pharmacists’ counselling. It might be more effective to plan interventions addressed to specific subgroups of patients or areas.

A 5-dimension patient education program targeting type 2 diabetes remission

2018 ◽  
Vol 10 (2) ◽  
pp. 20206
Author(s):  
Grégoire Lagger ◽  
Jorge Cesar Correia ◽  
Peter Fernandes ◽  
Frédéric Sittarame ◽  
Alain Golay
Keyword(s):  
Type 2 Diabetes ◽  
Patient Education ◽  
Glycemic Control ◽  
Drug Treatment ◽  
Education Program ◽  
Diabetes Remission ◽  
Therapeutic Education ◽  
Antidiabetic Drug ◽  
Type 2 Diabetes Remission

Introduction: Type 2 diabetes (T2D) reversal has been demonstrated in patients undergoing bariatric surgery or low caloric diets. Objective: To investigate the effects of therapeutic patient education alone on T2D reversal in early diagnosed patients. Methods: Seventeen T2D patients underwent a one-week therapeutic education program, followed by 12 months of 1 hour sessions every month, targeting diabetes reversal. This reversal was determined using the DiaRem score which integrates glycated hemoglobin levels and antidiabetic drug treatment. Patient’s conceptions, perceptions and motivation were assessed using a 5-dimensional psychopedagogic score. Results: After 1 year, the mean HbA1C fell from 7.2% (± 1.9) to 6.2% (± 0.8) (p < 0.05), antidiabetic drug doses decreased by 25% (p < 0.05), and the DiaRem score increased by 15% (p < 0.01), indicating a reversal of the disease, not correlated to weight loss. At the end of the study, 15 out of 17 patients had excellent glycemic control (HbA1C < 7.0%) and 4 patients had parameters compatible with partial diabetes remission. A significant improvement in glycemic control coupled with a lowering of antidiabetic drug treatment was observed. Conclusions: Following an initial therapeutic education program and regular consultation sessions thereafter, early diagnosed patients may reverse their type 2 diabetes.

Sign in / Sign up

Export Citation Format

Share Document